Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

6.93
+0.30004.52%
Post-market: 6.90-0.0294-0.42%19:50 EDT
Volume:6.47M
Turnover:44.04M
Market Cap:1.45B
PE:-38.89
High:6.93
Open:6.67
Low:6.59
Close:6.63
52wk High:11.31
52wk Low:6.00
Shares:209.92M
Float Shares:207.69M
Volume Ratio:0.44
T/O Rate:3.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1782
EPS(LYR):-0.4300
ROE:587.33%
ROA:7.46%
PB:-3.45
PE(LYR):-16.12

Loading ...

Bicara sinks after J&J reports head and neck cancer data

TIPRANKS
·
11 hours ago

BioCryst price target raised to $26 from $24 at Cantor Fitzgerald

TIPRANKS
·
Oct 15

RBC Raises Price Target on BioCryst Pharmaceuticals to $15 From $14, Keeps Outperform Rating

MT Newswires Live
·
Oct 15

BioCryst Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Oct 15

U.S. RESEARCH ROUNDUP- BlackRock, EQT, Ovintiv

Reuters
·
Oct 15

BioCryst Pharmaceuticals Inc : TD Cowen Reinstates Coverage With Buy Rating; Target Price $30

THOMSON REUTERS
·
Oct 15

BioCryst reinstated with a Buy at TD Cowen

TIPRANKS
·
Oct 15

RBC Capital Reaffirms Their Buy Rating on BioCryst (BCRX)

TIPRANKS
·
Oct 15

BioCryst price target raised to $15 from $14 at Jefferies

TIPRANKS
·
Oct 15

BioCryst Pharmaceuticals Down Over 10%, on Track for Lowest Close Since June 2024 -- Data Talk

Dow Jones
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-Spyre Therapeutics, Astria, Walmart

Reuters
·
Oct 15

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires Live
·
Oct 15

Hold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges

TIPRANKS
·
Oct 15

BioCryst Pharmaceuticals Shares Down 3%

THOMSON REUTERS
·
Oct 14

BioCryst Pharmaceuticals Shares Down 9.5% Premarket

THOMSON REUTERS
·
Oct 14

Astria Therapeutics Shares up 35.7% Premarket on BioCryst's $700 Million Buyout Deal

THOMSON REUTERS
·
Oct 14

BioCryst to acquire Astria Therapeutics for $13.00 per share

TIPRANKS
·
Oct 14

BRIEF-BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile

Reuters
·
Oct 14

BioCryst Pharmaceuticals to Acquire Astria Therapeutics, Expanding HAE Portfolio and Securing Strategic Financing

Reuters
·
Oct 14

Astria Therapeutics Inc - BioCryst to Pay $8.55 Cash and 0.59 Shares per Astria Share

THOMSON REUTERS
·
Oct 14